Cargando…

SARS-CoV-2 incidence and effect on absences at a university hospital in Germany

BACKGROUND: The COVID-19 pandemic highlighted the challenges and risks of in-hospital exposures among the health workforce. Health facilities were compelled to conduct their operation while both securing patient care and employees’ health in the context of changing regulatory requirements. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhelyazkova, A, Bonigut, M, Weber, M, Geiser-Metz, S, Geis, M, Heindl, B, Mayr, T, Prueckner, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595350/
http://dx.doi.org/10.1093/eurpub/ckad160.411
_version_ 1785124849654431744
author Zhelyazkova, A
Bonigut, M
Weber, M
Geiser-Metz, S
Geis, M
Heindl, B
Mayr, T
Prueckner, S
author_facet Zhelyazkova, A
Bonigut, M
Weber, M
Geiser-Metz, S
Geis, M
Heindl, B
Mayr, T
Prueckner, S
author_sort Zhelyazkova, A
collection PubMed
description BACKGROUND: The COVID-19 pandemic highlighted the challenges and risks of in-hospital exposures among the health workforce. Health facilities were compelled to conduct their operation while both securing patient care and employees’ health in the context of changing regulatory requirements. METHODS: We performed Time Series Models and a T-Test for Polymerase Chain Reaction (PCR) SARS-CoV-2 in-hospital test results reported via the digital COVID-19 platform of the LMU University Hospital, Germany. The cohort consists of all persons employed at the hospital during the platform's utilisation (N = 14,419; 11.2021-12.2022). RESULTS: Overall, 179,135 in-hospital PCR tests were executed (monthly range: 5,528-24,560; R2=.993) of which 6,538 were positive (monthly range: 92-1,095; R2=.991). In a symptomless or evanescent course of infection, employees were able to get a control test and resume their duties prior to the designated end of isolation if their viral load were below the benchmark of, initially, 100,000 or, as adapted later, 1,000,000 copies/ml (as per Robert Koch Institute's recommendation): 8,100 PCR control results below the respective benchmark were reported (monthly range: 92-1,429; R2=.995). In total, 6,841 persons were able to resume duties prior to their isolation expiration date (monthly range: 10-1,478; R2=.996). No significant differences between the monthly number of PCR tests indicating a new infection and control tests were observed (t=−1.246, p=.235). Incidence trends were tracked closely via the hospital's platform. CONCLUSIONS: The number of executed and positively reported tests fluctuated considerably. The benchmark for PCR tests in positive symptomless or evanescent cases allowed for a large number of staff to resume their duties prior to the expiration of their mandated isolation, yet without presenting a risk to other employees or patients. This measure prevented major staff shortages and ensured the uninterrupted provision of patient care at the hospital. KEY MESSAGES: • The establishment of a control test process facilitates the risk-reduced resumption of duty following a positive PCR test and reduces the isolation period with a decisive effect on staff capacity. • In-hospital test surveillance requires evidence-informed and agile adaptations, thus highlighting the need for centralised strategic management, including segmented visualisation and analysis.
format Online
Article
Text
id pubmed-10595350
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105953502023-10-25 SARS-CoV-2 incidence and effect on absences at a university hospital in Germany Zhelyazkova, A Bonigut, M Weber, M Geiser-Metz, S Geis, M Heindl, B Mayr, T Prueckner, S Eur J Public Health Parallel Programme BACKGROUND: The COVID-19 pandemic highlighted the challenges and risks of in-hospital exposures among the health workforce. Health facilities were compelled to conduct their operation while both securing patient care and employees’ health in the context of changing regulatory requirements. METHODS: We performed Time Series Models and a T-Test for Polymerase Chain Reaction (PCR) SARS-CoV-2 in-hospital test results reported via the digital COVID-19 platform of the LMU University Hospital, Germany. The cohort consists of all persons employed at the hospital during the platform's utilisation (N = 14,419; 11.2021-12.2022). RESULTS: Overall, 179,135 in-hospital PCR tests were executed (monthly range: 5,528-24,560; R2=.993) of which 6,538 were positive (monthly range: 92-1,095; R2=.991). In a symptomless or evanescent course of infection, employees were able to get a control test and resume their duties prior to the designated end of isolation if their viral load were below the benchmark of, initially, 100,000 or, as adapted later, 1,000,000 copies/ml (as per Robert Koch Institute's recommendation): 8,100 PCR control results below the respective benchmark were reported (monthly range: 92-1,429; R2=.995). In total, 6,841 persons were able to resume duties prior to their isolation expiration date (monthly range: 10-1,478; R2=.996). No significant differences between the monthly number of PCR tests indicating a new infection and control tests were observed (t=−1.246, p=.235). Incidence trends were tracked closely via the hospital's platform. CONCLUSIONS: The number of executed and positively reported tests fluctuated considerably. The benchmark for PCR tests in positive symptomless or evanescent cases allowed for a large number of staff to resume their duties prior to the expiration of their mandated isolation, yet without presenting a risk to other employees or patients. This measure prevented major staff shortages and ensured the uninterrupted provision of patient care at the hospital. KEY MESSAGES: • The establishment of a control test process facilitates the risk-reduced resumption of duty following a positive PCR test and reduces the isolation period with a decisive effect on staff capacity. • In-hospital test surveillance requires evidence-informed and agile adaptations, thus highlighting the need for centralised strategic management, including segmented visualisation and analysis. Oxford University Press 2023-10-24 /pmc/articles/PMC10595350/ http://dx.doi.org/10.1093/eurpub/ckad160.411 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Zhelyazkova, A
Bonigut, M
Weber, M
Geiser-Metz, S
Geis, M
Heindl, B
Mayr, T
Prueckner, S
SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title_full SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title_fullStr SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title_full_unstemmed SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title_short SARS-CoV-2 incidence and effect on absences at a university hospital in Germany
title_sort sars-cov-2 incidence and effect on absences at a university hospital in germany
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595350/
http://dx.doi.org/10.1093/eurpub/ckad160.411
work_keys_str_mv AT zhelyazkovaa sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT bonigutm sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT weberm sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT geisermetzs sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT geism sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT heindlb sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT mayrt sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany
AT prueckners sarscov2incidenceandeffectonabsencesatauniversityhospitalingermany